Nuvectis Pharma, Inc., was incorporated under the laws of the State of Delaware on July 27, 2020. The company is a clinical-stage biopharmaceutical company focused on the development of precision medicines for serious diseases with unmet medical needs in oncology. The company conducts drug candidate screening and clinical development based on scientific research on carcinogenic factors and understanding of the clinical and regulatory environment, and carries out targeted development projects to advance innovative treatment options. 

NVCT

NVCT Profile